| Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia V Griggio, F Perutelli, C Salvetti, E Boccellato, M Boccadoro, C Vitale, ... Frontiers in Immunology 11, 594556, 2020 | 47 | 2020 |
| Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs C Vitale, C Salvetti, V Griggio, M Porrazzo, L Schiattone, G Zamprogna, ... Blood, The Journal of the American Society of Hematology 137 (25), 3507-3517, 2021 | 35 | 2021 |
| Potential novel biomarkers in chronic graft-versus-host disease RE Crossland, F Perutelli, K Bogunia-Kubik, N Mooney, ... Frontiers in Immunology 11, 602547, 2020 | 23 | 2020 |
| Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia C Vitale, E Boccellato, L Comba, R Jones, F Perutelli, V Griggio, M Coscia Cancers 13 (15), 3856, 2021 | 19 | 2021 |
| The polycomb BMI1 protein is co-expressed with CD26+ in leukemic stem cells of chronic myeloid leukemia S Galimberti, S Grassi, C Baratè, F Guerrini, E Ciabatti, F Perutelli, F Ricci, ... Frontiers in Oncology 8, 555, 2018 | 17 | 2018 |
| Targeting HIF-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in CLL C Vitale, V Griggio, C Riganti, M Todaro, J Kopecka, R Jones, C Salvetti, ... Cancers 13 (12), 2883, 2021 | 13 | 2021 |
| Review of genetic variation as a predictive biomarker for chronic graft-versus-host-disease after allogeneic stem cell transplantation J Partanen, K Hyvärinen, H Bickeböller, K Bogunia-Kubik, RE Crossland, ... Frontiers in Immunology 11, 575492, 2020 | 13 | 2020 |
| Immunotherapeutic strategies in chronic lymphocytic leukemia: advances and challenges F Perutelli, R Jones, V Griggio, C Vitale, M Coscia Frontiers in Oncology 12, 837531, 2022 | 12 | 2022 |
| Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia F Perutelli, MC Montalbano, E Boccellato, M Coscia, C Vitale Current Opinion in Oncology 34 (6), 757-767, 2022 | 8 | 2022 |
| Real life use of bendamustine in elderly patients with lymphoid neoplasia I Dogliotti, S Ragaini, F Vassallo, E Boccellato, G De Luca, F Perutelli, ... Journal of Personalized Medicine 11 (4), 249, 2021 | 6 | 2021 |
| Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia G D’Arena, C Vitale, M Coscia, D Lamorte, G Pietrantuono, F Perutelli, ... Cancers 13 (16), 4239, 2021 | 5 | 2021 |
| Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia R Moia, R Dondolin, MS De Propris, D Talotta, S Mouhssine, F Perutelli, ... Hematological oncology 41 (3), 567-570, 2023 | 4 | 2023 |
| CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep? C Vitale, V Griggio, F Perutelli, M Coscia HemaSphere 7 (12), e988, 2023 | 2 | 2023 |
| Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia C Vitale, V Griggio, M Todaro, C Riganti, R Jones, E Boccellato, ... Scientific Reports 13 (1), 16950, 2023 | 2 | 2023 |
| Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy J Weng, CC Le, Y Pan, F Perutelli, X Cheng, J Cao, O Agbedia, SQ Kuang, ... Blood 142, 6827, 2023 | | 2023 |
| CLL-347 Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation F Perutelli, E Boccellato, G Catania, AM Frustaci, I Innocenti, R Moia, ... Clinical Lymphoma Myeloma and Leukemia 23, S325-S326, 2023 | | 2023 |
| POSTER: CLL-347 Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation F Perutelli, E Boccellato, G Catania, AM Frustaci, I Innocenti, R Moia, ... Clinical Lymphoma Myeloma and Leukemia 23, S172, 2023 | | 2023 |
| CD200 AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): MORE THAN A SURFACE MARKER. THE RELEVANCE OF ITS SERUM LEVELS IN PREDICTING PROGNOSIS G D'Arena, C Vitale, M Coscia, D Lamorte, G Pietrantuono, F Perutelli, ... HAEMATOLOGICA 106 (10), 100-100, 2021 | | 2021 |
| CLL-220: Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib F Perutelli, V Griggio, C Vitale, FR Mauro, C Salvetti, E Boccellato, ... Clinical Lymphoma Myeloma and Leukemia 20, S224-S225, 2020 | | 2020 |
| WT1 (WILMS'TUMOR1) GENE EXPRESSION AS PREDICTIVE AND PROGNOSTIC MARKER IN CHRONIC MYELOID LEUKEMIA (CML) S Coluzzi, T Introcaso, F Perutelli, SP Pascale, O Villani, F Guerrini, ... HAEMATOLOGICA 104, 143-143, 2019 | | 2019 |
